SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-027462
Filing Date
2019-07-31
Accepted
2019-07-31 16:01:25
Documents
54
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q apls-10q_20190630.htm   iXBRL 10-Q 1948600
2 EXHIBIT 10.1.DOCX apls-ex101_11.htm EX-10.1 117088
3 EX-10.2 SECOND AMENDMENT apls-ex102_184.htm EX-10.2 49589
4 EX-31.1 apls-ex311_10.htm EX-31.1 18215
5 EX-31.2 apls-ex312_6.htm EX-31.2 17557
6 EX-32.1 apls-ex321_9.htm EX-32.1 8568
7 EX-32.2 apls-ex322_7.htm EX-32.2 8577
8 GRAPHIC gdmlkae0ztv5000001.jpg GRAPHIC 24927
  Complete submission text file 0001564590-19-027462.txt   4855638

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA apls-20190630.xsd EX-101.SCH 34185
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE apls-20190630_cal.xml EX-101.CAL 42596
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE apls-20190630_def.xml EX-101.DEF 88264
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE apls-20190630_lab.xml EX-101.LAB 269785
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apls-20190630_pre.xml EX-101.PRE 195815
14 EXTRACTED XBRL INSTANCE DOCUMENT apls-10q_20190630_htm.xml XML 396002
Mailing Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014
Business Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014 502-241-4114
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38276 | Film No.: 19988694
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences